Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Shepherd et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69deab246bae133e7de948b5 — DOI: https://doi.org/10.1056/nejmoa050753

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Severe acute interstitial pneumonia and gefitinib· 2003 · 456 citations
2. New Guidelines to Evaluate the Response to Treatment in Solid Tumors· 2000 · 15,708 citations
3. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials· 1996 · 2,517 citations
4. Minimization Procedure· 2003 · 6 citations
5. Can rash associated with HER1/EGFR inhibition be used as a marker of treatment outcome?· 2003 · 152 citations